Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor

Biochemical and Biophysical Research Communications

Volumn 411, Issue 2, 2011, Pages 253-258

  Xiao, Xiaodong ^a,b   Feng, Yang ^a   Zhu, Zhongyu ^a   Dimitrov, Dimiter S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDIMMUNE   (United States)

Author keywords

CCHFV; Gc; Gn; Nucleolin; Receptor; Receptor binding domain

Indexed keywords

GLYCOPROTEIN; NUCLEOLIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; CODON; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; VIRUS ENTRY; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN INTERACTION MAPPING; RNA-BINDING PROTEINS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS;

EID: 79960847321     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.109     Document Type: Article

References (30)

1. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antivir. Res. 2004, 64:145-160.
2. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 2006, 6:203-214.
3. Keshtkar-Jahromi M., Kuhn J.H., Christova I., Bradfute S.B., Jahrling P.B., Bavari S. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antivir. Res. 2011, 90:85-92.
4. Treatment of Crimean-Congo Hemarrhagic Fever 2007, Springer, New York. O. Ergonul, C.A. Whitehouse (Eds.).
5. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., Mackow E.R. Cellular entry of Hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 1999, 73:3951-3959.
6. Bertolotti-Ciarlet A., Smith J., Strecker K., Paragas J., Altamura L.A., McFalls J.M., Frias-Staheli N., Garcia-Sastre A., Schmaljohn C.S., Doms R.W. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 2005, 79:6152-6161.
7. Haferkamp S., Fernando L., Schwarz T.F., Feldmann H., Flick R. Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins. Virol. J. 2005, 2:42.
8. Sanchez A.J., Vincent M.J., Nichol S.T. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 2002, 76:7263-7275.
9. Paragas J., Whitehouse C.A., Endy T.P., Bray M. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antivir. Res. 2004, 62:21-25.
10. Schmaljohn C.A.H.J. Bunyaviridae: The Viruses and Their Replication 2001, Lippincott Williams & Wilkins, Philadelphia.
11. Xiao X., Chakraborti S., Dimitrov A.S., Gramatikoff K., Dimitrov D.S. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem. Biophys. Res. Commun. 2003, 312:1159-1164.
12. Mongelard F., Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol. 2007, 17:80-86.
13. Bose S., Basu M., Banerjee A.K. Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells. J. Virol. 2004, 78:8146-8158.
14. Nisole S., Said E.A., Mische C., Prevost M.C., Krust B., Bouvet P., Bianco A., Briand J.P., Hovanessian A.G. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. J. Biol. Chem. 2002, 277:20877-20886.
15. de Verdugo U.R., Selinka H.C., Huber M., Kramer B., Kellermann J., Hofschneider P.H., Kandolf R. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol. 1995, 69:6751-6757.
16. Sinclair J.F., O'Brien A.D. Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. J. Biol. Chem. 2002, 277:2876-2885.
17. Burt F.J., Swanepoel R., Shieh W.J., Smith J.F., Leman P.A., Greer P.W., Coffield L.M., Rollin P.E., Ksiazek T.G., Peters C.J., Zaki S.R. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 1997, 121:839-846.
18. Semenkovich C.F., Ostlund R.E., Olson M.O., Yang J.W. A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin. Biochemistry 1990, 29:9708-9713.
19. Seddiki N., Nisole S., Krust B., Callebaut C., Guichard G., Muller S., Briand J.P., Hovanessian A.G. The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures. AIDS Res. Hum. Retroviruses 1999, 15:381-390.
20. Hirano K., Miki Y., Hirai Y., Sato R., Itoh T., Hayashi A., Yamanaka M., Eda S., Beppu M. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J. Biol. Chem. 2005, 280:39284-39293.
21. Shi H., Huang Y., Zhou H., Song X., Yuan S., Fu Y., Luo Y. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007, 110:2899-2906.
22. Christian S., Pilch J., Akerman M.E., Porkka K., Laakkonen P., Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol. 2003, 163:871-878.
23. Ginisty H., Sicard H., Roger B., Bouvet P. Structure and functions of nucleolin. J. Cell Sci. 1999, 112(Pt. 6):761-772.
24. Fogal V., Sugahara K.N., Ruoslahti E., Christian S. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 2009, 12:91-100.
25. Destouches D., El Khoury D., Hamma-Kourbali Y., Krust B., Albanese P., Katsoris P., Guichard G., Briand J.P., Courty J., Hovanessian A.G. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 2008, 3:e2518.
26. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit Hantavirus-directed permeability. J. Virol. 2008, 82:5797-5806.
27. Legrand D., Vigie K., Said E.A., Elass E., Masson M., Slomianny M.C., Carpentier M., Briand J.P., Mazurier J., Hovanessian A.G. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 2004, 271:303-317.
28. Hovanessian A.G., Puvion-Dutilleul F., Nisole S., Svab J., Perret E., Deng J.S., Krust B. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp. Cell Res. 2000, 261:312-328.
29. Simon M., Johansson C., Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-pH- and cholesterol-dependent. J. Gen. Virol. 2009, 90:210-215.
30. Simon M., Johansson C., Lundkvist A., Mirazimi A. Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 2009, 385:313-322.